Colorectal serrated pathway cancers and precursors
- 29 September 2014
- journal article
- review article
- Published by Wiley in Histopathology
- Vol. 66 (1), 49-65
- https://doi.org/10.1111/his.12564
Abstract
The serrated pathway (SP) can be viewed as two parallel, but partially overlapping, arrays of colorectal precursor lesions, and their respective endpoint carcinomas, that are distinct from those of the conventional adenoma–carcinoma sequence (APC‐pathway). In this review we focus at the outset on the clinical impact, pathological features, molecular genetics and biological behaviours of the various SP cancers. Then we summarize the clinicopathological features, classification and molecular profiles of the two main precursor lesions that anchor the respective pathways: (i) sessile serrated adenoma/polyp (SSA/P), also called sessile serrated lesion (SSL), and (ii) traditional serrated adenoma (TSA). Activating mutations of the RAS–RAF–MAPK pathway initiate and sustain the lesions of the SP, and CpG island methylation of the promoter regions of tumour suppressor and DNA repair genes play the major role in their neoplastic progression. The SP includes microsatellite stable (MSS) carcinomas that are among the most biologically aggressive colorectal carcinomas (CRC), and also accounts for the great preponderance of sporadic hypermutated, mismatch repair (MMR)‐deficient or microsatellite instable (MSI) CRC. The identification, removal and appropriate classification of at‐risk SP precursors and surveillance of individuals who harbour these lesions present a challenge and opportunity for CRC prevention and mortality reduction.Keywords
This publication has 105 references indexed in Scilit:
- PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and SurvivalPLOS ONE, 2013
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal ColonThe American Journal of Surgical Pathology, 2012
- High colonoscopic prevalence of proximal colon serrated polyps in average-risk men and womenGastrointestinal Endoscopy, 2012
- Up and downregulation of p16Ink4a expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancerLaboratory Investigation, 2011
- Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinomaHistopathology, 2011
- V600E Braf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16
INK4a
EMBO Molecular Medicine, 2010
- p21 in cancer: intricate networks and multiple activitiesNature Reviews Cancer, 2009
- Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancerGut, 2007
- Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancerHistopathology, 2006